看護師 の 指導 に よる 仮想 血液 凝固 防止 プログラム は 品質 を 向上 さ せ,費用 を 削減 する
Kristin Negley1, Gina Foster, Angela Mattson
1Author Affiliations: Department of Nursing, Mayo Clinic, Rochester, Minnesota (Dr Mattson, Mr Timm, Mss Negley and Foster) and Department of Nursing, Mayo Clinic Health System (Ms Foster and Dr O'Connor).
Nursing administration quarterly
|August 28, 2025
まとめ
この研究は看護師が主導する 抗凝固プログラムが成功し 患者の治療成果と費用対効果を向上させることを強調しています 法律改革の必要性を強調し,独立した看護師のサービス請求を支援する.
科学分野:
- 介護
- 薬理学について
- 医療管理
背景:
- 登録看護師 (RN) は,複雑な薬の管理を含む,外来治療の専門技能を持っています.
- 臨床医や薬剤師を含む チームの役割を最適化することで 患者のケアが向上します
- RNの専門知識を活用することで 既存の医療モデルを改善できます
研究 の 目的:
- 看護師主導の 凝固抑制プログラムについて
- 患者の治療の成果と 費用対効果を証明するために
- 独立した看護師の請求を認める法律改革を提唱する.
主な方法:
- 看護師による抗凝固プログラムを実施する.
- 看護師に敏感な指標の測定
- チームベースのケア,効率的なワークフロー,そして支援的な組織文化に焦点を当ててください.
主要な成果:
- このプログラムは 患者の治療に成功しました
- このプログラムは費用対効果が 高いことが証明されました
- RNは薬の管理における専門的なスキルの適用を示した.
結論:
- 看護師が主導するプログラムは 患者のケアと効率を大幅に改善できます
- 支援する組織文化と 強いリーダーシップが 成功に不可欠です
- すべての介護施設で 医療費を独立に請求できるように 法律改革が必要である.
関連する概念動画
Venous Thrombosis III: Interprofessional Care
22
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
22
Venous Thrombosis IV: Nursing Management
22
Nursing management begins with a thorough assessment of the patient's health history. Key factors include trauma to veins, peripherally inserted central catheters, varicose veins, recent pregnancy or childbirth, surgery, bacteremia, prolonged bed rest, atrial fibrillation, COPD, heart failure, cancer, coagulation disorders, myocardial infarction, spinal cord injury, stroke, prolonged travel, recent bone fractures, and dehydration. Review medication intake, particularly oral contraceptives,...
22
Anticoagulant Drugs: Low-Molecular-Weight Heparins
889
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
889
Cardiac Catheterization IV: Nursing Management
193
Nursing responsibilities before cardiac catheterization include:Assess for allergies and establish baseline health status.Before cardiac catheterization, assess the patient for allergies to contrast dye. Perform a comprehensive baseline assessment, including vital signs, heart and breath sounds, and a neurovascular assessment of the extremities, noting distal pulses, skin color, and temperature. Instruct the patient to fast for 8-12 hours before the procedure. Evaluate baseline laboratory...
193
Nursing Implementation
5.3K
Implementation is the execution of the nursing care plan developed during the planning phase.
The five steps to implementing effective nursing care include reassessing the patient, reviewing and revising the existing nursing care plan, organizing the resources and care delivery, anticipating and preventing complications, and implementing nursing interventions.
The five steps to implementing effective nursing care include reassessing the patient, reviewing and revising the existing nursing care plan, organizing the resources and care delivery, anticipating and preventing complications, and implementing nursing interventions.
5.3K
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants
1.3K
Oral anticoagulants are vital tools in preventing and treating blood clotting disorders. This diverse class of medications can be categorized as vitamin K antagonists, exemplified by warfarin, and direct thrombin inhibitors (DTIs), such as dabigatran, as well as factor Xa inhibitors, including rivaroxaban.
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
1.3K


